by CCH Admin | Mar 3, 2021 | Sponsors
Started: 10/2018 Study Name: Protocol Title: A Phase 3, Multicenter, Randomized, Double-blind Study to Evaluate the Interchangeability of XXX and Prevnar 13™ with Respect to Safety, Tolerability, and Immunogenicity in Healthy Infants (PNEU-DIRECTION) Indication:...
by CCH Admin | Mar 3, 2021 | Sponsors
Started: 7/2018 Study Name: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Pivotal Study to Evaluate the Safety and Efficacy of XXX Topical Film-Forming Solution [0.7% (w/v) Cantharidin] in Subjects (2 years and older) with Molluscum Contagiosum Indication:...
by CCH Admin | Mar 3, 2021 | Sponsors
Started: 8/2018 Study Name: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Pivotal Study to Evaluate the Safety and Efficacy of XXX Topical Film-Forming Solution [0.7% (w/v) Cantharidin] in Subjects (2 years and older) with Molluscum Contagiosum Indication:...
by CCH Admin | Mar 3, 2021 | Sponsors
Started: 6/2018 Study Name: A Phase 2, Open Label Study to Evaluate the Safety, Efficacy and Systemic Exposure of XXX Topical Film Forming Solution [0.7% (w/v) cantharidin] in Subjects (2 years and older) with Molluscum Contagiosum. Indication: Molluscum Principal...
by CCH Admin | Mar 3, 2021 | Sponsors
Started: 11/2018 Study Name: CP40559 – A Multicenter, Single-Arm, Open-Label Study To Assess The Safety, Pharmacokinetics, And Efficacy Of XXX In Otherwise Healthy Pediatric Patients From Birth To <1 Year With Influenza-Like Symptoms Indication: Influenza...
